We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Surgical strike

10 January 2011 By Robert Cole

The UK orthopedics group is in play, with U.S. rival J&J the likely predator. A low rating makes S&N vulnerable, although management can plausibly argue it deserves an $11 blnplus valuation. Either way, its first step should be to clarify the status of any approach it has had.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)